Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as patient characteristics, treatment, and disease outcomes, and overall patient outcomes.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Diagnoza neuroendokrynnego raka szyjki macicy (w tym nowotwory mieszane)
- •Pacjenci na dowolnym etapie leczenia, obserwacji lub nawrotu choroby
- •Wszyscy pacjenci, niezależnie od stopnia zaawansowania choroby
- •Pacjenci leczeni w dowolnym ośrodku medycznym na świecie
- •Pacjenci z dowolnego kraju i każdego pochodzenia etnicznego
- •Osoby bliskie lub reprezentanci prawni zmarłych pacjentów ze zdiagnozowanym nowotworem
- •Pacjenci mówiący innymi językami z dostępnym tłumaczem
✗ Disqualifies
- •Pacjenci z innymi podtypami neuroendokrynnego raka szyjki macicy (np. guzy karcinoidalne)
Simplified criteria — AI translation
Trial details
- Last updated (source)
- September 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
M D Anderson Cancer Center
Houston, United States
Trial contact
Larissa A. Meyer, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.